USD 0.81
(-5.81%)
Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
---|---|---|---|---|---|---|
Revenue | - | - | - | - | - | - |
Cost of Revenue | 1.6 Million | 1.6 Million | 1.6 Million | 1.6 Million | 5.6 Million | - |
Gross Profit | -1.6 Million | -1.6 Million | -1.6 Million | -1.6 Million | -5.6 Million | - |
Operating Expenses | 16.21 Thousand | 16.39 Thousand | 15.51 Thousand | 14.33 Thousand | 17.93 Thousand | 5.62 Million |
Selling, General and Administrative Expenses | 16.21 Thousand | 16.39 Thousand | 15.51 Thousand | 14.33 Thousand | 17.93 Thousand | 5.62 Million |
Research and Development Expenses | - | - | - | - | - | - |
Other Expenses | - | - | - | - | - | - |
Cost and Expenses | 1.61 Million | 1.61 Million | 1.61 Million | 1.61 Million | 5.61 Million | 5.62 Million |
Operating Income | -1.61 Million | -1.61 Million | -1.61 Million | -1.61 Million | -5.61 Million | -5.62 Million |
Interest Expense | - | - | - | - | - | - |
Income Tax Expense | 1.00 | - | - | - | - | -161.14 Thousand |
Earnings before Tax | -1.61 Million | -1.61 Million | -1.61 Million | -1.61 Million | -5.61 Million | 49.8 Million |
Net Income | -1.61 Million | -1.61 Million | -1.61 Million | -1.61 Million | -5.61 Million | 49.8 Million |
Earnings Per Share Basic | -0.02 | -0.02 | -0.02 | -0.02 | -0.08 | 0.71 |
Earnings Per Share Diluted | -0.02 | -0.02 | -0.02 | -0.02 | -0.08 | 0.71 |
Weighted Average Shares Outstanding | 70 Million | 70 Million | 70 Million | 70 Million | 70 Million | 70 Million |
Weighted Average Shares Outstanding (Diluted) | 70 Million | 70 Million | 70 Million | 70 Million | 70 Million | 70 Million |
Gross Margin | - | - | - | - | - | - |
EBIT Margin | - | - | - | - | - | - |
Profit Margin | - | - | - | - | - | - |
EBITDA | -16.21 Thousand | -16.39 Thousand | -15.51 Thousand | -14.33 Thousand | -17.93 Thousand | 49.8 Million |
Earnings Before Tax Margin | - | - | - | - | - | - |
Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
---|---|---|---|---|---|---|
Revenue | - | - | - | - | - | - |
Cost of Revenue | 400 Thousand | 400 Thousand | 1.6 Million | 400 Thousand | 400 Thousand | 400 Thousand |
Gross Profit | -400 Thousand | -400 Thousand | -1.6 Million | -400 Thousand | -400 Thousand | -400 Thousand |
Operating Expenses | 2993.00 | 4993.00 | 16.21 Thousand | 3212.00 | 5719.00 | 2412.00 |
Selling, General and Administrative Expenses | 2993.00 | 4993.00 | - | 3212.00 | 5719.00 | 2412.00 |
Research and Development Expenses | - | - | - | - | - | - |
Other Expenses | - | - | - | - | - | - |
Cost and Expenses | 402.99 Thousand | 404.99 Thousand | 1.61 Million | 403.21 Thousand | 405.71 Thousand | 402.41 Thousand |
Operating Income | -402.99 Thousand | -404.99 Thousand | -1.61 Million | -403.21 Thousand | -405.72 Thousand | -402.41 Thousand |
Interest Expense | - | - | - | - | - | - |
Income Tax Expense | - | - | 1.00 | - | - | - |
Earnings before Tax | -402.99 Thousand | -404.99 Thousand | -1.61 Million | -403.21 Thousand | -405.71 Thousand | -402.41 Thousand |
Net Income | -402.99 Thousand | -404.99 Thousand | -1.61 Million | -403.21 Thousand | -405.71 Thousand | -402.41 Thousand |
Earnings Per Share Basic | -0.01 | -0.01 | - | -0.01 | -0.01 | -0.01 |
Earnings Per Share Diluted | -0.01 | -0.01 | - | -0.01 | -0.01 | -0.01 |
Weighted Average Shares Outstanding | 70 Million | 70 Million | 70 Million | 70 Million | 70 Million | 70 Million |
Weighted Average Shares Outstanding (Diluted) | 70 Million | 70 Million | 70 Million | 70 Million | 70 Million | 70 Million |
Gross Margin | - | - | - | - | - | - |
EBIT Margin | - | - | - | - | - | - |
Profit Margin | - | - | - | - | - | - |
EBITDA | -2990.00 | -4990.00 | - | -3210.00 | -5720.00 | -2410.00 |
Earnings Before Tax Margin | - | - | - | - | - | - |
PEB-PG
ABLV
FNINF
7TEC
BVNNF
ARTEMISMED